Exploring the Latest Advances in Ophthalmology: Yuvezzi

What is Yuvezzi?

𝕐𝕦𝕧𝕖𝕫𝕫𝕚 is the 𝐟𝐢𝐫𝐬𝐭 𝐚𝐧𝐝 𝐨𝐧𝐥𝐲 𝐝𝐮𝐚𝐥-𝐚𝐠𝐞𝐧𝐭 𝐞𝐲𝐞 𝐝𝐫𝐨𝐩 approved by FDA for 𝐩𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚. (𝘑𝘢𝘯𝘶𝘢𝘳𝘺 28𝘵𝘩 2026)

🟠𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐭𝐰𝐨 𝐤𝐞𝐲 𝐜𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭𝐬?🟠

𝟏. 𝐂𝐚𝐫𝐛𝐚𝐜𝐡𝐨𝐥 𝟐.𝟕𝟓%

🔸Cholinergic agonist

🔸Constricts the pupil

𝟐. 𝐁𝐫𝐢𝐦𝐨𝐧𝐢𝐝𝐢𝐧𝐞 𝐭𝐚𝐫𝐭𝐫𝐚𝐭𝐞 𝟎.𝟏%

🔹Alpha-adrenergic agonist

🔹Helps maintain pupil constriction

🔹Reduces side effects like redness

🟢𝐇𝐨𝐰 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐰𝐨𝐫𝐤?🟢

The combo creates a 𝐩𝐢𝐧𝐡𝐨𝐥𝐞 𝐞𝐟𝐟𝐞𝐜𝐭 by temporarily constricting the pupil → 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐬 𝐝𝐞𝐩𝐭𝐡 𝐨𝐟 𝐟𝐨𝐜𝐮𝐬 and s𝐡𝐚𝐫𝐩𝐞𝐧𝐬 𝐧𝐞𝐚𝐫 𝐯𝐢𝐬𝐢𝐨𝐧

🟣𝐇𝐨𝐰 𝐝𝐨 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐛𝐞𝐧𝐞𝐟𝐢𝐭?🟣

Patients, in the presbyopic age group(over 40yrs), can read, work on phone/computer without glasses or surgery.

🟤𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐝𝐨𝐬𝐢𝐧𝐠?🟤

:One drop in each eye once daily. Effect starts in about 30 minutes and lasts up to 8–10 hours

🔴𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬?🔴

Headache

Eye irritation